Slide 1: Analyst presentation: 2026 first three months results
Winning together as a team Analyst presentation 2026 first three months results 30 April 2026
Slide 2: Presenting team
Presenting team Marcus Jordan Hans Kooijmans CEO CFO 2
Slide 3: Highlights Q1 2026, Financials, Outlook, Q&A, Annex
1 Highlights Q1 2026 2 Financials Q1 2026 3 Outlook 4 Q&A 5 Annex 3
Slide 4: Highlights Q1 2026: Financial results
Highlights Q1 2026: Financial results Cash earnings per Gross profit Operating EBITA Free cash flow share EUR 312 million EUR 130 million EUR 121 million EUR 1.46 +1% on a constant -2% on a constant Q1 2025: EUR 102 Q1 2025: EUR 1.55 currency basis currency basis million 4
Slide 5: Financials
Highlights Financials Outlook Q&A Annex Q1 2026 Q1 2026
Slide 6: Financials Q1 2026 – key figures
Financials Q1 2026 – key figures FX adj. EUR million Q1 2026 Q1 2025 Change Change % change Revenue 1,267 1,260 7 1% 6% Gross profit 312 325 (13) (4%) 1% Gross profit as a % of revenue 24.6% 25.8% (1.2%) Operating EBITA 130 142 (12) (9%) (2%) Operating EBITA as a % or revenue 10.2% 11.3% (1.1%) Conv
Slide 7: Financials Q1 2026 – segment information
Financials Q1 2026 – segment information Asia- Holding EUR million EMEA Americas Pacific companies Total Gross profit Q1 2026 156 83 73 312 Q1 2025 149 101 75 325 organic growth (0%) (11%) (1%) (4%) acquisition growth 7% 0% 7% 5% currency impact (2%) (7%) (10%) (5%) Operating EBITA Q1 2026 66 31 41
Slide 8: Financials Q1 2026 – Free cash flow
Financials Q1 2026 – Free cash flow EUR million Q1 2026 Q1 2025 Change Change % Operating EBITA 130 142 (12) (9%) Depreciation 11 10 0 4% Operating EBITDA 141 152 (12) (8%) Lease payments (8) (9) 1 (7%) Share based payments 1 1 (0) (16%) Adjusted operating EBITDA 133 145 (11) (8%) Capex (1) (2) 0 (1
Slide 9: Financials Q1 2026 – net debt
Financials Q1 2026 – net debt 31 March 31 December 31 March EUR million 2026 2025 2025 Reported net debt: 1,504 1,552 1,228 Reported leverage ratio: Reported (incl. full year impact of acquisitions) 2.8 2.8 2.1 Leverage ratio based on loan documentation: Actual based on loan documentation 2.7 2.7 2.
Slide 10: Outlook
Highlights Financials Outlook Q&A Annex Q1 2026 Q1 2026
Slide 11: Outlook
Outlook IMCD operates in different, often fragmented market segments in multiple geographic regions, connecting many customers and suppliers across a very diverse product range. In general, results are impacted by macroeconomic conditions and developments in specific industries. Results can be influ
Slide 12: Q&A
Highlights Financials Outlook Q&A Annex Q1 2026 Q1 2026
Slide 13: Annex
Highlights Financials Outlook Q&A Annex Q1 2026 Q1 2026
Slide 14: We are IMCD
We are IMCD IMCD is a leading global partner for the distribution and formulation of speciality chemicals and ingredients. ● Adaptable business model driving simplification for our partners ● Formulatory and solutions provider ● Comprehensive and complementary specialty portfolio ● Global footprint
Slide 15: 8 business groups, focusing on strategic market segments
8 business groups, focusing on strategic market segments Pharmaceuticals Coatings & Construction Food & Nutrition Advanced Materials Excipients; APIs; nutraceuticals; Coatings; decorative paints; Dairy; savoury; bakery; beverage; Compounders; converters; synthesis; agrochemicals; adhesives & sealant
Slide 16: High scores on external ESG ratings
High scores on external ESG ratings Demonstrating our continuous focus on best practices B- (Prime) ESG Risk Score C (2025) Rating A (2026) rating Platinum (2025) Rating 11.6, Score B (2024) on a scale of C+ rating (2024) Gold (2024) low risk (2025) On a scale of A AAA-CCC On a scale of A+ 12.6 (202
Slide 17: Disclaimer
Disclaimer This presentation may contain forward looking statements. These statements are based on current expectations, estimates and projections of IMCD’s management and information currently available to the company. IMCD cautions that such statements contain elements of risk and uncertainties th